47 results
424B4
PPCB
Propanc Biopharma, Inc.
16 Oct 23
Prospectus supplement with pricing info
8:21pm
” benefit from overseas research and development (“R&D”) expenses. The finding relates to the planned Phase Ib clinical trial - Multiple Ascending Dose … into clinical trials, continue our R&D, seek regulatory approvals, establish or contract for a sales and marketing infrastructure, maintain and expand
424B3
u51g81aup
4 Apr 23
Prospectus supplement
11:22am
424B3
upw de917e0ko870lhz
22 Feb 22
Prospectus supplement
11:53am
POS AM
1r872tvovxki
10 Jan 22
Prospectus update (post-effective amendment)
4:46pm